Dear Friends and Colleagues,

It is our pleasure to invite you to attend the 11th International Congress on Myeloproliferative Neoplasms, to be held on October 25-26, 2018 in New York, New York.

Since its inception 17 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists, translational scientists, and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including chronic myeloid leukemia, the hypereosinophilic syndromes, and mastocytosis.

This year’s CME-accredited program will feature the latest information on the pathophysiology and management of these disorders through lectures, interactive question-and-answer sessions and a peer-reviewed scientific abstract session. 

New features this year include a discussion of myeloproliferative neoplasms in childhood and adolescence, a series of debates between experts on controversial management issues such as when to initiate interferon therapy, the role of cytoreduction in essential thrombocytosis and the use of ruxolitinib relative to hydroxyurea.

We hope you will join us for what has become the premier forum for discussion of the latest advances in the myeloproliferative neoplasms!

Warm regards,

Richard T. Silver, MD

Weill Cornell Medicine

New York, New York, USA

Chairman, 11th International Congress on MPNs

Jerry L. Spivak, MD

Johns Hopkins University School of Medicine

Baltimore, Maryland, USA

Co-Chairman, 11th International Congress on MPNs